|
|
F-dopa PET successfully discriminates normal subjects from parkinsonian patients,and patients with Parkinson's disease from patients with SRO,but is less reliable in distinguishing Parkinson's disease from MSA.The concomitant assessment of striatal neuronal function with additional PET tracers may be necessary to reliably differentiate typical and atypical parkinsonian syndromes. |
|